Integra LifeSciences Holdings Corp Stock
A loss of -1.160% shows a downward development for Integra LifeSciences Holdings Corp.
Our community is currently low on Integra LifeSciences Holdings Corp with 1 Buy predictions and 5 Sell predictions.
This results in a negative potential of -47.37% based on a current price of 17.1 € and a target price of 9 € for the stock.
Pros and Cons of Integra LifeSciences Holdings Corp in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
B****
Cons
?
S********** s********
?
C******** o* t** e**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Integra LifeSciences Holdings Corp vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Integra LifeSciences Holdings Corp | -1.160% | 3.636% | 4.908% | 54.054% | 61.321% | -57.673% | -71.017% |
| Haemonetics Corp. | 2.840% | 5.797% | 7.353% | - | 6.569% | - | - |
| Bio-Rad Labs Inc. A | -0.480% | 6.562% | 10.604% | 30.681% | 10.818% | -24.392% | -51.966% |
| CONMED Corp. | -2.590% | 4.918% | 28.000% | -10.698% | 9.714% | -64.112% | -67.179% |
Comments
Integra LifeSciences (IART) was upgraded by Argus from "hold" to "buy". They now have a $25.00 price target on the stock.
Show more
Ratings data for IART provided by MarketBeat
Integra LifeSciences (IART) had its price target raised by Citigroup Inc. from $9.00 to $11.00. They now have a "sell" rating on the stock.
Show more
Ratings data for IART provided by MarketBeat
Integra LifeSciences (IART) had its price target lowered by Citigroup Inc. from $11.00 to $9.00. They now have a "sell" rating on the stock.
Show more
Ratings data for IART provided by MarketBeat
News
Integra LifeSciences Q2 Earnings Call Highlights
Key Points
- Interested in Integra LifeSciences Holdings Corporation? Here are five stocks we like better.
- Q2 results exceeded expectations: Revenue rose 0.8% to $419 million, while adjusted EPS
Integra Resources Q1 Earnings Call Highlights
Integra Resources (NYSEAMERICAN:ITRG) reported first-quarter 2026 results that management said reflected a deliberate reinvestment phase at its Florida Canyon mine, alongside continued permitting